Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Healthtrust
US Department of Justice
Merck
UBS
Cantor Fitzgerald
McKesson
Teva
Baxter
AstraZeneca

Generated: February 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,943,621

« Back to Dashboard

Which drugs does patent 7,943,621 protect, and when does it expire?

Patent 7,943,621 protects VRAYLAR and is included in one NDA.

This patent has thirty patent family members in thirty countries.
Summary for Patent: 7,943,621
Title:Salts of piperazine compounds as D.sub.3/D.sub.2 antagonists
Abstract: The present invention relates to novel monohydrochloride, dihydrochloride, monohydrobromide, maleate and methanesulphonate salts of trans 4-{2-[4-(2,3-dichlorophenyl)-piperazine-1-yl]-ethyl}-N,N-dimethylca- rbamoyl-cyclohexylamine and/or their hydrates and/or solvates. Moreover, the invention relates to the process for preparing the salts and their hydrates and/or solvates, to their use in the treatment and/or prevention of conditions which require modulation of dopamine receptor and to pharmaceutical compositions containing them.
Inventor(s): Czibula; Laszlo (Budapest, HU), Sebok; Ferenc (Mezokovacshaza, HU), Greiner; Istvan (Budapest, HU), Domany; Gyorgy (Obanya, HU), Csongor; Eva Againe (Budapest, HU)
Assignee: Richter Gedeon Nyrt. (Budapest, HU)
Application Number:12/118,437
Patent Claim Types:
see list of patent claims
Compound; Process; Composition;

Drugs Protected by US Patent 7,943,621

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Allergan Sales Llc VRAYLAR cariprazine hydrochloride CAPSULE;ORAL 204370-001 Sep 17, 2015 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Allergan Sales Llc VRAYLAR cariprazine hydrochloride CAPSULE;ORAL 204370-002 Sep 17, 2015 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Allergan Sales Llc VRAYLAR cariprazine hydrochloride CAPSULE;ORAL 204370-003 Sep 17, 2015 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Allergan Sales Llc VRAYLAR cariprazine hydrochloride CAPSULE;ORAL 204370-004 Sep 17, 2015 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,943,621

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2008249772 ➤ Try a Free Trial
Brazil PI0811199 ➤ Try a Free Trial
Canada 2684404 ➤ Try a Free Trial
China 101679315 ➤ Try a Free Trial
Colombia 6241112 ➤ Try a Free Trial
Denmark 2155696 ➤ Try a Free Trial
Eurasian Patent Organization 017270 ➤ Try a Free Trial
Eurasian Patent Organization 200971046 ➤ Try a Free Trial
Ecuador SP099772 ➤ Try a Free Trial
European Patent Office 2155696 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
UBS
US Army
Farmers Insurance
Argus Health
Citi
Johnson and Johnson
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot